A Multi-Center, Individually-Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Superiority Trial to Evaluate the Efficacy of the Combination of Maraviroc and Atorvastatin for the Treatment of Subjects With Long COVID
Clinical trial NCT06974084 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT06974084
- Sponsor
- HealthBio, Inc.
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2026-07-15
- Primary completion
- 2026-12-01
- Enrollment
- 252
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.